P. Dellamonica

Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

J. Durant, Philippe Clevenbergh, Philippe Halfon et al. · The Lancet · 1999 · 762 citations

Life Sciences, Pharmacotherapy, Molecular Virology +15

HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term Combination Antiretroviral Therapy Reach Same Mortality Rates as the General Population

Charlotte Lewden, Geneviève Chêne, Philippe Morlat et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2007 · 395 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +16

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres

Y Mouton, S. Alfandari, M. Valette et al. · AIDS · 1997 · 363 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Christian Brun‐Buisson, Jean Carlet, P. Dellamonica et al. · PubMed · 1995 · 342 citations

Veterinary Medicine, Infectious Diseases, Acute Care Medicine +16

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

J. Durant, Philippe Clevenbergh, R. Garraffo et al. · AIDS · 2000 · 223 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +17